Israeli Basketball Legend Miki Berkovich Battles Progressive Lewy Body Dementia

Miki Berkovich, one of Israel's most celebrated basketball players and a prominent figure of Maccabi Tel Aviv, is currently facing Lewy Body Dementia (LBD), a progressive neurodegenerative brain disease. This condition gradually impairs cognitive functions, alertness, movement, sleep, and behavior. It is characterized by fluctuations in cognitive performance, visual hallucinations, and symptoms similar to Parkinson's disease, such as slowed movement, muscle stiffness, tremors, and balance issues.

Lewy Body Dementia results from abnormal accumulation of alpha-synuclein protein deposits, known as Lewy bodies, within nerve cells, disrupting brain chemistry. Patients may experience varying symptoms including concentration difficulties, spatial awareness problems, REM sleep behavior disorder, and autonomic nervous system dysfunctions like blood pressure changes, dizziness, and urinary control issues. The disease's progression and symptom severity differ widely among individuals.

Currently, there is no cure for LBD, and treatment focuses on symptom management to maintain quality of life. Therapies may include medications used for Alzheimer's cognitive symptoms and Parkinson's motor symptoms, physical therapy, tailored exercise, and environmental adjustments. However, caution is necessary with antipsychotic drugs, which can be harmful to LBD patients. Berkovich's family disclosed his condition recently, providing context for his reduced public presence.

Berkovich's diagnosis sheds light on the challenges posed by this complex disease, which does not always present with typical dementia symptoms like memory loss initially but rather with cognitive fluctuations and hallucinations. His battle highlights the need for accurate diagnosis and personalized care in managing Lewy Body Dementia.